New possibilities for treating rare diseases by optimising precise gene editing with CRISPR-Cas9
The two-week long national course took place at the Oslo Science Park 7 – 18 November.
Anita Kavlie, national coordinator for EATRIS Norway, has been involved in writing and organizing a new free MOOC developed under the European Joint Program of Rare Diseases with the title Introduction to translational research for Rare Diseases.
The study used HDX-MS to map the epitope and paratope of the new high-affinity tumor-specific antibody developed against a variant of HER2. Antibodies directed against HER2 are already used in breast cancer therapy, and the new antibody developed by the collaboration has potential to be used as a diagnostic tool or future cancer treatment.
NCMM Group Leader Dr Emma Haapaniemi will collaborate with centre leaders and NCMM Associate Investigators Prof Johanna Olweus and Prof Karl-Johan Malmberg as part of the new centre, Precision Immunotherapy Alliance (PRIMA).
Molecular discoveries have the potential to lead to advancements in the understanding and treatment of disease. Over 90 scientists visited Oslo to discuss the latest dynamic kinetochore research
Dr Tatiana Belova (NCMM), Dr Salim Ghannoum (Oslo University Hospital) and Saikat Das Sajib (University of Tromsø) have been awarded the funding by the national network for breast cancer research
Are you a scientist working on health-related topics in the life science domain? Do you have an idea for a new solution or technology with innovation potential, but need help to take the next steps? Apply for UiO:Life Science’s two-year innovation programme SPARK Norway. The last deadline was 10 November 2022.
Anita Kavlie, national coordinator for EATRIS Norway, pitched the benefits of the EATRIS research infrastructure to a full house at innovation hangouts – a new meeting place for academia and industry organised by the Life Science Growth House
The origin of life on Earth is one of humankind’s greatest open questions. Researchers at NCMM wanted to investigate how the transition from non-living to living matter on the early-Earth took place by studying how molecules like DNA and RNA are exchanged between primitive cells
On the 13th & 14th of June NCMM held its first scientific retreat in three years. The retreat comprised of two days of excellent talks from the research environment and Associate Investigator network representing NCMM’s wide expertise in molecular medicine
Where are they now? Meet NCMM alumna Rønnaug Steen Kolve and learn about her career path from studies in molecular medicine to managing first a core facility at an international research center and then research funding actions at the Norwegian Cancer Society.
Dr Liye He is a Postdoctoral Researcher with a background in computational science and precision medicine in the group of Professor Tero Aittokallio at FIMM. He recently spent time with the Mathelier group at NCMM
Elham Shojaeinia is a PhD student in the Esguerra group at NCMM. She recently visited DANDRITE at Aarhus University, Denmark to learn in depth about the principles of neural organization
NCMM group leader, Dr Marieke Kuijjer and Dr Xavier Tekpli (Oslo University Hospital) have been awarded the funding by the foundation for the promotion of cancer research (UNIFOR-FRIMED)
Abnormal epigenetic changes are observed in the development of multiple types of cancer. Researchers at NCMM wanted to explore the molecular mechanisms driving these processes
The NorMIC series of workshops has established itself as an important platform for Norway and Scandinavia-based biomedical researchers to gain scientific knowledge of optical microscopy
Ieva Rauluševičiūtė is a Doctoral Research Fellow in the Mathelier group at NCMM. She recently spent one month with the groups of Dr Judith Zaugg and Dr Arnaud Krebs at the EMBL Headquarters in Heidelberg, Germany.
NCMM is delighted to announce that Dr Charlotte Boccara has been recruited as a new group leader under the Centre’s precision medicine umbrella. Dr Boccara will join us in April 2022 . She will establish and head the Systems Neuroscience & Sleep group at NCMM, aiming to decode sleep function in healthy development.
In this article, we meet NCMM Group Leader and Zebrafish Core Facility Leader, Camila Esguerra, and learn about the power of zebrafish as a model organism and the core facility she directs at the University of Oslo.